THYMOSIN ALPHA (Tα1)

290.00 AED — In stock

Thymosin Alpha‑1 (Tα1) is a naturally occurring thymic peptide recognized for its powerful immune‑modulating properties. Originally isolated from the thymus gland, it plays a crucial role in stimulating T‑cell activity, enhancing immune defense mechanisms, reducing inflammation, and supporting resistance to infections. Thymosin Alpha‑1 has been widely studied in clinical settings related to immune regulation, chronic illness management, infection response, and systemic inflammation modulation. In modern wellness and longevity research, it is valued for its ability to strengthen immune balance, support inflammation control, and promote overall resilience. Key Features 🧪 cGMP manufactured in an FDA‑registered facility✅ ≥98% purity confirmed by HPLC analysis📄 Batch‑specific Certificates of Analysis (COAs) included💉 Sterile, lyophilized vials for research use only Human‑Relevant Research Applications 🛡️ Immune modulation & cellular defenseThymosin Alpha‑1 acts as an endogenous regulator of immune homeostasis and has been shown to influence dendritic cell function, T‑cell responses, and immune signaling pathways in humans.🔗 https://pubmed.ncbi.nlm.nih.gov/17495242/ 🧬 Clinical immune regulation effectsComprehensive clinical evidence indicates that Tα1 is safe and effective in modulating immune responses across a range of settings including infectious diseases, autoimmune conditions, and cancer therapy support.🔗 https://pubmed.ncbi.nlm.nih.gov/38308608/ ⚕️ Reduces inflammation & supports infection defenseMeta‑analysis data show Thymosin Alpha‑1 increases immune cell ratios (e.g., CD4+/CD8+) and can reduce inflammation and infection incidence in critical illness contexts.🔗 https://pubmed.ncbi.nlm.nih.gov/40599771/ Mechanism Summary Enhances T‑cell activation, differentiation, and adaptive immune response Modulates innate immune signaling and cytokine production Supports immune cell communication via Toll‑like receptor pathways Helps control inflammatory signaling and balance immune responsiveness Reconstitution & Handling Guidance 1️⃣ Use sterile bacteriostatic water (0.9% benzyl alcohol)2️⃣ Add 3 ml of bacteriostatic water to reconstitute the peptide3️⃣ Gently swirl — do not vortex — until fully dissolved4️⃣ Store reconstituted vial at 4 °C–10 °C for up to 2–3 months5️⃣ Unreconstituted peptide remains stable until expiry when stored at 4 °C–10 °C Frequently Asked Research Questions How does Thymosin Alpha‑1 support immune function?Tα1 enhances both innate and adaptive immune signaling, activating T‑cells and dendritic cells critical to pathogen defense and immune modulation. Is this peptide studied in human clinical contexts?Yes — extensive clinical data involving thousands of human subjects supports its safety and immune‑modulating effects in infectious and immune‑challenged populations. Legal & Research Disclaimer This material is supplied exclusively for laboratory research use. It is not intended for diagnostic, therapeutic, cosmetic, human, or veterinary applications. The purchaser assumes all responsibility for compliance with applicable local, state, and federal regulations governing research compounds.

More All Products

What is THYMOSIN ALPHA (Tα1)?

Thymosin alpha-1 is a 28-amino-acid peptide first isolated from thymosin fraction 5, an extract of calf thymus. It is naturally cut from a larger protein called prothymosin alpha. The synthetic form, thymalfasin, is identical to the natural peptide and carries an acetyl group at its start.

Thymosin alpha-1 is thought to act as an immune modulator. Research suggests it interacts with toll-like receptors on immune cells. It has been studied for effects on T cell maturation and on the balance between immune activation and tolerance.

Also known as: Thymalfasin, Tα1, TA1, Zadaxin

What are peptides?

What the research covers

Thymosin alpha-1 has a larger human evidence base than many peptides. It has been studied in clinical trials in chronic hepatitis B and C, as a vaccine adjuvant, in sepsis and alongside cancer treatment. Results vary by condition, and some meta-analyses report possible benefit while noting study quality concerns. Its use in healthy ageing has been studied far less, and early research in this area is largely theoretical. Thymalfasin is approved under the brand name Zadaxin in a number of countries, mainly for chronic hepatitis B and C. It is not approved by the US FDA.

References

Romani L, Bistoni F, Montagnoli C, et al.. Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance. Annals of the New York Academy of Sciences. 2007.

Formats available

Pen

Pre-filled pen for subcutaneous use, prescription only.

Cartridge

Refill cartridge for a reusable pen device, prescription only.

Vial (injectable)

Vial for subcutaneous injection, prepared by the pharmacy, prescription only.

Storage and handling

Storage: Vials are usually supplied lyophilised (freeze-dried). Once reconstituted, keep the vial refrigerated at 2-8°C, protected from light, and do not freeze. Pens and cartridges should be kept refrigerated at 2-8°C and protected from light. Follow the storage instructions on your pharmacy label.

Peptide Calculator

Specification

Property	Value
Sequence	Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN
Molecular formula	C129H215N33O55
Molecular weight	approx. 3108 g/mol
Peptide length	28 amino acids
Formats	Pen, Cartridge, Vial (injectable)

Frequently asked questions

Is this the same as Zadaxin?

Zadaxin is the branded form of thymalfasin, approved in some countries for chronic hepatitis B and C. Our product is a compounded preparation of the same peptide, prescribed by our GP. It is not the branded medicine.

How is thymosin alpha-1 different from Thymalin?

Thymosin alpha-1 is one defined 28-amino-acid peptide. Thymalin is a mixture of short thymus-derived peptides. Both have been studied for immune function.

Which formats are available and how do I store them?

We supply thymosin alpha-1 as a pen, cartridge or vial. Keep pens, cartridges and reconstituted vials refrigerated at 2-8°C. Follow the storage instructions on your pharmacy label.

Are there side effects?

Side effects can occur. Your GP will review your health, medication and, where relevant, blood results before prescribing, and you should report anything unexpected.

How much will I take?

Your dose is set by our licensed GP following a consultation, and printed on your pharmacy label.